Zacks Investment ResearchT3·6d ago
SURG SurgePays, Inc. Common Stock
XNAS 0.16 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
SURG
$0.16
—
What changed
Recent filings, trades and moves- Nov 11 Reports earnings
- Nov 3 8-K: Regulation FD disclosure
- Oct 15 Short interest down 12% to 2.9M shares
Key stats
$0.16
- 52-Week Range
- $0.11 – $2.92
- YTD
- -90.76%
- Straddle Price
- $0.82
- P/C Vol Ratio
- 2.37
- Market Cap
- $0.0B
- Open
- $0.17
- Day Range
- $0.15 – $0.17
- Volume
- 2,041,547
- Prev Close
- $0.17
Fair Value
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.77 |
| Cost of Equity (CAPM) | 8.76% (VRP-adj) |
| WACC | 7.19% |
| Volatility Risk Premium | +356.6pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | 155.2% |
| Book / Price | -203.6% |
| Gross Margin (TTM) | -19.6% |
| FCF Margin (TTM) | -23.0% |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $0.15 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $0.14 |
| Bollinger Width / SMA20 | 48.8% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
Blended Fair Value
—
Deviation
—
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | n/a | 0% | |
| Peer P/S | n/a | 0% | |
| Market Anchor (SMA50) | $0.15 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE) (4813) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 20
- List Date
- 2007-05-08
- CIK
- 0001392694
- Next Earnings
- 2026-11-11
- EPS Forecast
- ($0.07)
- Headquarters
- Bartlett, TN
- Homepage
- https://www.surgepays.com
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and dig…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | 40.67% | -8.73% | -1.41% | -17.42% | -33.33% | -4.04% |
| Feb | -- | 0.33% | -3.83% | 5.72% | -7.91% | -27.64% | -6.67% |
| Mar | -- | 32.90% | -20.39% | -49.34% | 80.00% | -10.81% | 6.47% |
| Apr | -- | -17.16% | -14.00% | -7.38% | 34.53% | -16.59% | -4.12% |
| May | -- | 30.69% | 61.41% | -0.81% | -2.83% | 3.52% | 18.40% |
| Jun | -- | 10.15% | 0.14% | -6.73% | 4.71% | -39.41% | -6.23% |
| Jul | -- | 39.18% | -18.87% | -4.84% | -10.13% | -46.83% | -8.30% |
| Aug | -- | -36.60% | -9.32% | -39.71% | 0.00% | -21.52% | -21.43% |
| Sep | -- | 7.82% | -9.48% | 27.78% | 3.69% | -3.84% | 5.19% |
| Oct | -- | 18.16% | -5.03% | -6.70% | 1.54% | 9.95% | 3.58% |
| Nov | -30.00% | 15.61% | 44.30% | 23.75% | -23.26% | 0.78%* | 5.20% |
| Dec | -19.84% | -8.12% | -4.59% | -4.30% | -12.11% | -- | -9.79% |
| Total | -43.89% | 167.10% | -15.42% | -63.35% | 19.58% | -89.99% | -4.33% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.14
SMA 50: $0.15
SMA 200: $0.48
Current: $0.16
EMA 12: $0.15
EMA 26: $0.15
MACD: 0.0030 | Signal: 0.0034
BEARISH
ADX (14): 21.06
WEAK TREND
+DI: 26.92
−DI: 15.43
Momentum Oscillators
RSI (14): 52.35
NEUTRAL
Stoch %K: 76.15
Stoch %D: 73.95
Williams %R: -35.14
Volume & Volatility
BB Upper: $0.18
BB Lower: $0.11
NEUTRAL
OBV: 966,291,338
Vol SMA 20: 5,642,226
Vol ROC: -51.43%
ATR: $0.02
True Range: $0.02
HV 20: 89.5%
HV 30: 84.3%
HV 60: 106.0%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
LLM Stock Analysis Report - SURG
Executive Summary
BULLISH with confidence level 6/10
Key drivers: Earnings beats, product launches, and revenue growth Primary risks: High volatility, negative news sentiment, technical breakdown
Recent news sentiment impact: Mixed signals from recent headlines, but overall bullish tone prevails
Technical Analysis
Trend Direction: Short-term downtrend (1-4 weeks), Medium-term range-bound (1-3 months), Long-term uptrend (3-12 months)
Support/Resistance Levels:
- SMA 20: $0.20
- SMA 50: $0.27
- Lower Bollinger Band: $0.11
Momentum Signals: RSI interpretation: Neutral (38.51) MACD signal: Bearish (histogram -0.03 below signal line 0.00) Bollinger Bands position: Neutral (price near middle band)
Volume Analysis: Volume trends indicate institutional interest and potential accumulation.
News & Sentiment Analysis
Recent Headlines Summary: Mixed news sentiment, with some positive headlines on revenue growth and product launches, while others focus on proposed underwritten public offerings.
Sentiment Assessment: Overall neutral sentiment, but leaning slightly bearish due to recent negative headlines.
Catalyst Identification: Earnings release in Q2 2025, potential catalyst for future price movement.
Risk & Volatility Assessment
Beta Interpretation: Moderate risk relative to market (beta 0.88).
Volatility Regime: High volatility regime with IV rank at 82.4% and IV premium vs HV30 at 333.0%.
Options Market Signals: Unusual put activity suggests bearish sentiment, while call options indicate some buying interest.
Downside Protection: Support levels at SMA 20 ($0.20) and Lower Bollinger Band ($0.11).
Market Context & Positioning
Sector Performance: SURG's beta indicates it tends to follow market movements, with a moderate correlation coefficient of 0.09.
Institutional Activity: Volume trends suggest institutional interest and potential accumulation.
Correlation Analysis: Moderate correlation with SPY (beta 0.88).
Relative Valuation: Position within trading range, but leaning slightly bearish due to recent negative headlines.
Key Levels & Action Items
Critical Price Levels: Support at SMA 20 ($0.20) and Lower Bollinger Band ($0.11), resistance at SMA 50 ($0.27).
Breakout/Breakdown Levels: Break above SMA 50 could trigger a bullish move, while break below SMA 20 could lead to further decline.
Time-Sensitive Catalysts: Earnings release in Q2 2025 and potential product launches.
Risk Management: Monitor volume and price action near support levels; consider stop-loss orders at SMA 20 ($0.20) and Lower Bollinger Band ($0.11).
This report provides a comprehensive analysis of SURG's stock performance, incorporating technical indicators, options metrics, beta analysis, market data, and recent news headlines. The overall assessment is BULLISH with a confidence level of 6/10, driven by earnings beats, product launches, and revenue growth. However, high volatility and negative news sentiment pose risks to the upside.
Generated
News
All SURG news →
The Motley FoolT3·6mo ago
BenzingaT3·9mo ago
BenzingaT3·12mo ago
BenzingaT3·14mo ago
BenzingaT3·15mo ago
BenzingaT3·18mo ago
BenzingaT3·23mo ago
BenzingaT3·24mo ago
Zacks Investment ResearchT3·28mo ago
Showing 1–10 of 50
Page 1 of 5
Earnings History
2 of 2 under expected move
Avg Expected Move
14.97%
Avg Actual Move
0.77%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2023-07-13 | After-Close | 12.48% | 1.54% | 0.12x | Within |
| 2025-11-13 | unknown | 17.46% | 0.00% | 0.00x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
SURG Options Activity & IV Rank
Volatility Metrics
Current IV: —
7-DTE IV: —
Expected Move: $0.82
7-DTE Move: $0.60
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 145
Put Volume: 344
P/C Volume: 2.372
BEARISH
Call OI: 9,468
Put OI: 1,342
P/C OI: 0.142
Total OI: 10,810
ATM Options Pricing
ATM Call: $0.45
ATM Put: $0.38
Call %: 284.8%
Put %: 237.3%
Chain Summary
Chain Volume: 489
Chain OI: 10,810
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 52nd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
52%
vs own history
GEX tilt
+0.43
OI-weighted, today
Vanna tilt
+0.55
δ-sensitivity to IV
Charm tilt
-0.63
δ-decay vs time
Vanna tilt +0.55: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.63: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 6 ATM contracts, 3k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$0.82Nov 9
Beta Analysis
Risk Metrics
Beta: 0.6723
Alpha: -203.35%
Correlation: 0.0739
R-Squared: 0.5%
Stock Volatility: 125.6%
Market Volatility: 13.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own SURG
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $30K | #6109 of 6285 | new | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $18K | #3097 of 3138 | +2.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
SURG Institutional Ownership (13F)
Filings for 2026-06-30 · 11 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 22,501,913 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
3 filers$22.05K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $19.53K | 88.55% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $2.38K | 10.77% | 2026-09-30 |
| 3 | Simplex Trading, LLC Custodian | $150 | 0.68% | 2026-09-30 |
1 filers$15 notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $15 | 100.00% | 2026-09-30 |
SURG Insider Trading (Form 4)
Latest: 2026-09-16Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Laurie Weisberg | Director | Award (A) | +315,179 | — | EDGAR | |
| 2026-09-14 | David N Keys | Director | Award (A) | +315,179 | — | EDGAR | |
| 2026-09-08 | David Allen May | Director | Award (A) | +315,179 | — | EDGAR | |
| 2026-06-05 | David Allen May | Director | Buy (P) | +40,250 | $0.53 | $21.2K | EDGAR |
| 2026-06-03 | Kevin Brian Cox | CEO & Chairman | Award (A) | +500,000 | — | EDGAR | |
| 2026-04-07 | Kevin Brian Cox | CEO & Chairman | Mixed Grant +1,300,000 · Gift +0 |
+1,300,000 | $1.25 | $1.00M | EDGAR |
| 2026-01-05 | Anthony George Evers | Chief Financial Officer | Award (A) | +200,000 | — | EDGAR | |
| 2025-12-11 | David Allen May | Director | Buy (P) | +38,422 | $1.60 | $61.6K | EDGAR |
| 2025-06-10 | David Allen May | Director | Sell (S) | −63,000 | $2.81 | -$177.3K | EDGAR |
| 2025-05-27 | Laurie Weisberg | Director | Award (A) | +50,000 | — | EDGAR | |
| 2025-05-27 | David N Keys | Director | Award (A) | +50,000 | — | EDGAR | |
| 2025-05-27 | Richard Earl Schurfeld | Director | Award (A) | +50,000 | — | EDGAR | |
| 2025-05-19 | Kevin Brian Cox | CEO and Chairman of Board | Buy (P) | +15,073 | $2.75 | $41.5K | EDGAR |
| 2024-12-04 | Kevin Brian Cox | CEO and Chairman of Board | Sell (S) | −35,180 | $1.82 | -$64.1K | EDGAR |
| 2024-12-04 | Anthony George Evers | Chief Financial Officer | Sell (S) | −36,666 | $1.86 | -$68.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
SURG Insider Holdings
6 insiders · @ $0.16
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Kevin Brian Cox | CEO & Chairman | 2,070,745 | $321.4K | -$73.2K | 5 | 2026-06-03 |
| 2 | David Allen May | Director | 486,805 | $75.6K | -$94.5K | 4 | 2026-09-08 |
| 3 | Anthony George Evers | Chief Financial Officer | 414,924 | $64.4K | -$126.9K | 3 | 2026-01-05 |
| 4 | David N Keys | Director | 412,059 | $64.0K | $0 | 2 | 2026-09-14 |
| 5 | Laurie Weisberg | Director | 406,868 | $63.1K | $14.0K | 3 | 2026-09-16 |
| 6 | Richard Earl Schurfeld | Director | 97,501 | $15.1K | $5.6K | 2 | 2025-05-27 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
SURG Board & Officers
As of SEC filings through Sep 16, 2026Directors 3
- Kevin Brian Cox · since Jul 26, 2017
- David N Keys · since Jul 17, 2019
- Laurie Weisberg · since Dec 19, 2022
Officers 1
- Kevin Brian Cox · CEO & Chairman · listed since Apr 2026
10% owners 1
- Kevin Brian Cox · listed since Apr 2026
Changes in the last 10 years (25)
| Apr 7, 2026 | Kevin Brian Cox listed as CEO & Chairman (previously CEO and Chairman of Board) in SEC filings |
| Apr 7, 2026 | Kevin Brian Cox first listed as a 10% owner in an SEC filing |
| Jan 7, 2026 | The company announced the departure of Richard Earl Schurfeld from the board in an SEC filing |
| Jan 7, 2026 | The company announced the departure of Anthony George Evers as Chief Financial Officer in an SEC filing |
| Jun 4, 2024 | Kevin Brian Cox listed as CEO and Chairman of Board (previously Chief Executive Officer) in SEC filings |
| May 3, 2024 | Kevin Brian Cox no longer listed as a 10% owner in SEC filings |
| Jan 8, 2024 | Jeremy Gies became President |
| Dec 19, 2022 | The company announced the departure of David Allen May from the board in an SEC filing |
| Dec 19, 2022 | Richard Earl Schurfeld became a director |
| Dec 19, 2022 | Laurie Weisberg became a director |
| Jun 6, 2022 | John Mott first listed as a director in an SEC filing |
| Apr 27, 2022 | David Allen May no longer listed as Director in SEC filings |
| Jan 18, 2022 | David Allen May first listed as Director in an SEC filing |
| Feb 23, 2021 | David Allen May became a director |
| Nov 25, 2020 | Anthony P. Nuzzo JR listed as President (previously President and COO) in SEC filings |
| Nov 2, 2020 | Anthony P. Nuzzo JR first listed as a 10% owner in an SEC filing |
| May 1, 2020 | Anthony George Evers became Chief Financial Officer |
| Jul 17, 2019 | David N Keys became a director |
| Oct 1, 2018 | John Mott became Chief Technology Officer |
| Aug 30, 2017 | David C Ansani became a director |
| Jul 26, 2017 | Kevin Brian Cox became a director |
| Jul 26, 2017 | Kevin Brian Cox became a 10% owner |
| Jul 26, 2017 | Kevin Brian Cox became Chief Executive Officer |
| Jul 26, 2017 | Anthony P. Nuzzo JR became a director |
| Jul 26, 2017 | Anthony P. Nuzzo JR became President and COO |
Not reported recently (4)
- Jeremy Gies · Last reported as President in an SEC filing dated Jan 17, 2024
- John Mott · Last reported as Chief Technology Officer in an SEC filing dated Jun 6, 2022
- Anthony P. Nuzzo JR · Last reported as a director in an SEC filing dated Sep 14, 2021
- David C Ansani · Last reported as a director in an SEC filing dated Oct 9, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
SURG Proposed Insider Sales (Form 144)
Latest: 2025-12-04
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | Evers Anthony George | Officer | 175,966 | $299.1K | 2025-12-04 | J.P. Morgan Securities LLC | 10b5-1 | EDGAR |
| 2024-12-03 | KEVIN B COX | Director, Officer | 35,180 | $65.4K | 2024-12-03 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-12-02 | Ansani David C | Officer | 8,335 | $15.5K | 2024-12-02 | Raymond James & Associates, Inc. | 10b5-1 | EDGAR |
| 2024-11-04 | KEVIN B COX | Director, Officer, 10% Stockholder | 31,700 | $50.7K | 2024-11-04 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-11-01 | Ansani David C | Officer | 8,333 | $13.3K | 2024-11-01 | Raymond James & Associates | 10b5-1 | EDGAR |
| 2024-11-01 | Evers Anthony George | Officer | 36,667 | $58.7K | 2024-11-01 | Raymond James & Associates | 10b5-1 | EDGAR |
| 2024-10-02 | Ansani David C | Officer | 8,333 | $13.9K | 2024-10-02 | Raymond James & Associates | 10b5-1 | EDGAR |
| 2024-10-02 | Evers Anthony George | Officer | 36,667 | $61.1K | 2024-10-02 | Raymond James & Associates | 10b5-1 | EDGAR |
| 2024-10-02 | KEVIN B COX | Director, Officer, 10% Stockholder | 32,375 | $58.0K | 2024-10-02 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-09-11 | Evers Anthony George | Officer | 2,000 | $6.0K | 2024-07-11 | RAYMOND JAMES & ASSOCIATES, INC. | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-03
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-03 | Regulation FD disclosure | EDGAR |
| 2026-10-15 | Regulation FD disclosure | EDGAR |
| 2026-09-29 | Listing standards notice | EDGAR |
| 2026-09-16 | Auditor change | EDGAR |
| 2026-09-10 | Material agreement · Acquisition or sale completed · Other events | EDGAR |
| 2026-09-03 | Other events | EDGAR |
| 2026-08-05 | Regulation FD disclosure · Other events | EDGAR |
| 2026-07-29 | Other events | EDGAR |
| 2026-07-01 | Other events | EDGAR |
| 2026-06-22 | Shareholder vote results | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-19 | 0001493152-26-039250 | EDGAR |
ETF Holders
1 ETF hold SURG
1 shown · $22.38K total exposure
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $22,384 | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-1.51
TTM Revenue
$67.06M
TTM Net Income
$-32.11M
TTM Op. Cash Flow
$-15.39M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $16.20M | $1.29M | $0.05 | $-2.63M |
| Q1 '26 | 2026-03-31 | $15.98M | $-12.05M | $-0.51 | $-4.55M |
| Q4 '25 | 2025-12-31 | $16.19M | $-13.86M | $-0.69 | $-3.56M |
| Q3 '25 | 2025-09-30 | $18.68M | $-7.49M | $-0.38 | $-4.65M |
| Q2 '25 | 2025-06-30 | $11.52M | $-7.08M | $-0.36 | $-6.12M |
| Q1 '25 | 2025-03-31 | $10.58M | $-7.64M | $-0.38 | $-6.96M |
| Q4 '24 | 2024-12-31 | $9.60M | $-19.81M | $-1.02 | $-7.90M |
| Q3 '24 | 2024-09-30 | $4.77M | $-14.28M | $-0.73 | $-13.32M |
| Q2 '24 | 2024-06-30 | $15.09M | $-12.87M | $-0.66 | $-4.13M |
| Q1 '24 | 2024-03-31 | $31.43M | $1.22M | $0.07 | $4.04M |
| Q4 '23 | 2023-12-31 | $32.32M | $3.02M | $0.19 | $1.96M |
| Q3 '23 | 2023-09-30 | $34.16M | $7.08M | $0.49 | $8.11M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-19
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
—
P/S
0.05
EV/EBITDA
—
EV/Sales
0.07
ROE
—
ROA
-347.6%
Div Yield
0.00%
FCF Yield
-440.73%
Debt/Equity
—
Current Ratio
—
Market Cap
$3.49M
as of 2026-11-09
SURG vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| VZ Verizon Communications | $189.4B | 11.7 | +1.4% | +13.3% | 20 |
| T AT&T Inc. | $145.7B | 11.7 | +3.5% | −12.1% | 47 |
| AMX America Movil S.A.B de C.V American Depo | $76.8B | — | — | +26.5% | 15 |
| TEF Telefonica, S.A. | $21.5B | — | — | −5.0% | — |
| BCE BCE, Inc. | $20.2B | — | — | −9.2% | 54 |
| VIV Telefonica Brasil, S.A. American Deposit | $18.3B | — | — | −4.0% | 79 |
| TLK PT Telekomunikasi Indonesia | $10.9B | — | — | −45.9% | — |
| FYBR Frontier Communications Parent, Inc. Com | $9.6B | — | +4.3% | +1.1% | — |
| SURG SurgePays, Inc. Common Stock | $10M | — | +83.9% | −90.9% | — |
| Peer median | $20.8B | 11.7 | +3.5% | −4.5% | 47 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
2.88M
SI % of Float
16.08%
Days to Cover
1.23
Short Vol Ratio
52.6%
Free Float
17.93M
Float %
71.4%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-05-15